Insilico Medicine and MIKADO team up to find new treatments for cystinosis
A team led by researchers at the Mechanisms of Inherited Kidney Disorders (MIKADO) group at the University of Zurich (Zurich, Switzerland) has used Insilico Medicine's generative artificial intelligence (AI) target discovery engine, PandaOmics, to identify actionable drug targets for the lysosomal storage disease cystinosis and to validate them in preclinical models of the disease.
Olivier Devuyst Alessandro Luciani Alex Zhavoronkov Danielle Ellis Microsoft Research University Of Zurich
Source: news-medical.net